Keywords: دیسکینزی ناشی از لوودوپا; Parkinson's disease; Levodopa-induced dyskinesia; Computer vision; Clinimetric testing; Objective assessment;
مقالات ISI دیسکینزی ناشی از لوودوپا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دیسکینزی ناشی از لوودوپا; Dyskinesia; Parkinson's disease; Levodopa; Nitric oxide; NOS1 gene; LID; Levodopa-induced dyskinesia; PD; Parkinson's disease; MDS-UPDRS; International Parkinson and Movement Disorders Society - Unified Parkinson's Disease Rating Scale; SNP; single nucleo
Keywords: دیسکینزی ناشی از لوودوپا; AMPA; α-amino-3-hydroxy-5-methyl-4- isoxazole propionic acid; ASI; Axon-spine interface; Ca2+; calcium; CNS; Central nervous system; CS-EP; Corticostriatal-evoked potential; DBS; deep brain stimulation; DA; Dopamine; DARPP-32; dopamine-regulated neuronal
Keywords: دیسکینزی ناشی از لوودوپا; AC; adenylate cyclase; ADHD; attention deficit hyperactivity disorder; ACC; anterior cingulate cortex; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; adenosine triphosphate; BBB; blood-brain barrier;
Keywords: دیسکینزی ناشی از لوودوپا; 6-OHDA; 6-hydroxydopamine; ABC; avidin-biotin-peroxidase complex; AIM; abnormal involuntary movement; DDS; dopamine dysregulation syndrome; IT; intratelencephalic; LID; levodopa-induced dyskinesia; PD; Parkinson's disease; PT; pyramidal tract; Dendritic
Keywords: دیسکینزی ناشی از لوودوپا; BBB; blood brain barrier; 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; H215O; 15O-water; FDG; 18F-fluorodeoxyglucose; CBF; cerebral blood flow; CMR; cerebral metabolic rate for glucose; GP; globus pallidus; LID; levodopa-induced dyskinesia; VOI; vo
Keywords: دیسکینزی ناشی از لوودوپا; Anosognosia; Self-awareness; Parkinson's disease; Dyskinesia; Neurodegenerative disorder; BDI-2; Beck-Depression-Inventory 2; DRT; dopamine replacement therapy; FDG; 18F-2fluoro-2-deoxy-d-glucose; FWE; family-wise error; IFG; inferior frontal gyrus; ISA;
Keywords: دیسکینزی ناشی از لوودوپا; Parkinson's disease; Levodopa-induced dyskinesia; Sleep; Synaptic homeostasis; Slow-wave activity;
Keywords: دیسکینزی ناشی از لوودوپا; Parkinson's disease; Levodopa-induced dyskinesia; Topiramate; Clinical trial;
Keywords: دیسکینزی ناشی از لوودوپا; Essential tremor; Brain; Genetics; Human population; Mouse models; Pathophysiology; ABA; Allen brain atlas; AβPPswe/PS1ÎE9; amyloid-β protein precursor and presenilin-1; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; ATP; adenosine tri-ph
Keywords: دیسکینزی ناشی از لوودوپا; Parkinson's disease; Levodopa-induced dyskinesia; Clinical phenotype;
CaMKII inhibition ameliorated levodopa-induced dyskinesia by downregulating tyrosine hydroxylase activity in an experimental model of Parkinson's disease
Keywords: دیسکینزی ناشی از لوودوپا; Ca(2+)/calmodulin-dependent protein kinase II; Dopamine; Levodopa-induced dyskinesia; Parkinson's disease; Protein kinase A; Tyrosine hydroxylase;
mGlu4 allosteric modulation for treating Parkinson's disease
Keywords: دیسکینزی ناشی از لوودوپا; Parkinson's disease; Dyskinesia; Glutamate; Dopamine; mGlu4; 6-OHDA; 6-hydroxydopamine; ADX88178; 4-methyl-N-[5-methyl-4-(1H-pyrazol-4-yl)-1,3-thiazol-2-yl]pyrimidin-2-amine; AIM; abnormal involuntary movements; CODA-RET; complemented donor acceptor reson
Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats
Keywords: دیسکینزی ناشی از لوودوپا; Parkinson's disease; Levodopa-induced dyskinesia; Zonisamide; Adenosine; Endocannabinoid;
Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia
Keywords: دیسکینزی ناشی از لوودوپا; A2AR; Adenosine 2A receptor; AIM; abnormal involuntary movement; ANOVA; analysis of variance; BPND; non-displaceable binding potential; CNS; central nervous system; D2R; dopamine type 2 receptor; L-DOPA; levodopa; LID; levodopa-induced dyskinesia; MRTM; I
Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP/p mouse model of Parkinson's disease
Keywords: دیسکینزی ناشی از لوودوپا; PD; Parkinson's disease; MPTP/p; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine plus probenecid; l-DOPA; levodopa; LID; levodopa-induced dyskinesia; MAPK; mitogen-activated protein kinase; pERK; phosphorylated extracellular signal-regulated kinase; tERK;
Short communicationOverexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors
Keywords: دیسکینزی ناشی از لوودوپا; Parkinson's disease; Levodopa-induced dyskinesia; Dopamine receptor agonist; Tolerance; Adeno-associated virus; PD; Parkinson's disease; LID; levodopa-induced dyskinesia; AIMs; abnormal involuntary movements; EGFP; enhanced green fluorescent protein; l-DO
Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of l-dopa by normalizing Parkinson's disease-induced neurochemical imbalance
Keywords: دیسکینزی ناشی از لوودوپا; Levodopa-induced dyskinesia; Acupuncture; Parkinson's disease; l-dopa combination treatment; GABA; FosB
Sustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats
Keywords: دیسکینزی ناشی از لوودوپا; Levodopa methyl ester(LDME)/benserazide-loaded microspheres; Parkinson's disease; Levodopa-induced dyskinesia; ÎfosB; Dopamine; cAMP-regulated phosphoprotein of 32Â kDa; Extracellular signal-regulated kinases 1 and 2;
Consensus paper: Use of transcranial magnetic stimulation to probe motor cortex plasticity in dystonia and levodopa-induced dyskinesia
Keywords: دیسکینزی ناشی از لوودوپا; dystonia; levodopa-induced dyskinesia; Parkinson's disease; plasticity; musicians; TMS
GABAB receptor activation inhibits dopamine D1 receptor-mediated facilitation of [3H]GABA release in substantia nigra pars reticulata
Keywords: دیسکینزی ناشی از لوودوپا; Direct pathway; GABA release; GABAB autoreceptors; Levodopa-induced dyskinesia; Striatonigral transmission; Substantia nigra reticulata
The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias
Keywords: دیسکینزی ناشی از لوودوپا; Neural transplantation; 6-hydroxydopamine; Levodopa-induced dyskinesia; Abnormal involuntary; Movement; Girk2; Tyrosine hydroxylase; DARPP-32; Cdk5
The beneficial effects of subthalamic nucleus stimulation on manipulative finger force control in Parkinson's disease
Keywords: دیسکینزی ناشی از لوودوپا; Grip force; Parkinson's disease; STN stimulation; Levodopa-induced dyskinesia;